On Biostatistics and Clinical Trials
CQ's web blog on the issues in biostatistics and clinical trials.
Showing posts with label
Statistical analysis
.
Show all posts
Showing posts with label
Statistical analysis
.
Show all posts
Monday, May 01, 2023
Violin plot versus Box-Whisker Plot
›
A box and whisker plot (Also called: box plot, box-whisker diagram) is defined as a graphical method of displaying variation in a set of da...
Sunday, January 15, 2023
Rank Preserving Structural Failure Time Model (RPSFTM) to account for treatment crossover
›
In a previous post " Treatment crossover in parallel-group, randomized, controlled clinical trials ", treatment crossover was disc...
Sunday, January 08, 2023
Treatment crossover in parallel-group, randomized, controlled clinical trials
›
Randomized, controlled clinical trial (RCT) is the golden standard in drug development. RCTs are usually designed as parallel-group to compa...
1 comment:
Tuesday, November 15, 2022
Treatment Emergent AEs (TEAEs), On-Study AEs, On-Treatment AEs, Non-TEAEs
›
During the clinical trial, the adverse events (AEs) are collected from the signing of the informed consent to the last dose of the study dru...
Monday, August 22, 2022
Story of BrainStorm's Stem Cell Treatment for ALS - Criticality of the Statistical Analyses
›
This past week, the biotech company BrainStorm announced the decision to submit a BLA to the FDA for NurOwn® (a stem cell treatment) for th...
›
Home
View web version
